{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T01:59:03Z","timestamp":1778551143918,"version":"3.51.4"},"reference-count":33,"publisher":"Pharmaceutical Society of Japan","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological & Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2013]]},"DOI":"10.1248\/bpb.b12-00760","type":"journal-article","created":{"date-parts":[[2013,1,8]],"date-time":"2013-01-08T20:55:31Z","timestamp":1357678531000},"page":"125-130","source":"Crossref","is-referenced-by-count":21,"title":["Intrathecal Ketamine and Pregabalin at Sub-effective Doses Synergistically Reduces Neuropathic Pain without Motor Dysfunction in Mice"],"prefix":"10.1248","volume":"36","author":[{"given":"Hyung Sun","family":"Lim","sequence":"first","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, School of Medicine, Chonbuk National University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Min","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Physiology and Institute of Brain Research, School of Medicine, Chungnam National University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Gyun","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Physiology and Institute of Brain Research, School of Medicine, Chungnam National University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Kwon","family":"Ko","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, School of Medicine, Chungnam National University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong Sup","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, School of Medicine, Chungnam National University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beyong Hwa","family":"Jeon","sequence":"additional","affiliation":[{"name":"Department of Physiology and Institute of Brain Research, School of Medicine, Chungnam National University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Bong","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Physiology and Institute of Brain Research, School of Medicine, Chungnam National University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jang-Hern","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Veterinary Physiology, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun-Woo","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Physiology and Institute of Brain Research, School of Medicine, Chungnam National University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Vranken JH. Mechanisms and treatment of neuropathic pain. Cent. Nerv. Syst. Agents Med. Chem.<\/i>, 9<\/b>, 71–78 (2009).","DOI":"10.2174\/187152409787601932"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Peters CM, Ghilardi JR, Keyser CP, Kubota K, Lindsay TH, Luger NM, Mach DB, Schwei MJ, Sevcik MA, Mantyh PW. Tumor-induced injury of primary afferent sensory nerve fibers in bone cancer pain. Exp. Neurol.<\/i>, 193<\/b>, 85–100 (2005).","DOI":"10.1016\/j.expneurol.2004.11.028"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Scholz J, Woolf CJ. Can we conquer pain? Nat. Neurosci.<\/i>, 5<\/b> (Suppl.), 1062–1067 (2002).","DOI":"10.1038\/nn942"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Ossipov MH, Lai J, Malan TP Jr, Porreca F. Spinal and supraspinal mechanisms of neuropathic pain. Ann. N. Y. Acad. Sci.<\/i>, 909<\/b>, 12–24 (2000).","DOI":"10.1111\/j.1749-6632.2000.tb06673.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Zimmermann M. Pathobiology of neuropathic pain. Eur. J. Pharmacol.<\/i>, 429<\/b>, 23–37 (2001).","DOI":"10.1016\/S0014-2999(01)01303-6"},{"key":"6","unstructured":"6) Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet<\/i>, 353<\/b>, 1959–1964 (1999)."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Luo ZD, Chaplan SR, Higuera ES, Sorkin LS, Stauderman KA, Williams ME, Yaksh TL. Upregulation of dorsal root ganglion α2δ calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats. J. Neurosci.<\/i>, 21<\/b>, 1868–1875 (2001).","DOI":"10.1523\/JNEUROSCI.21-06-01868.2001"},{"key":"8","unstructured":"8) Bian F, Li Z, Offord J, Davis MD, McCormick J, Taylor CP, Walker LC. Calcium channel α2-δ type 1 subunit is the major binding protein for pregabalin in neocortex, hippocampus, amygdala, and spinal cord: an ex vivo<\/i> autoradiographic study in α2-δ type 1 genetically modified mice. Brain Res.<\/i>, 1075<\/b>, 68–80 (2006)."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Fink K, Dooley DJ, Meder WP, Suman-Chauhan N, Duffy S, Clusmann H, Göthert M. Inhibition of neuronal Ca2+<\/sup> influx by gabapentin and pregabalin in the human neocortex. Neuropharmacology<\/i>, 42<\/b>, 229–236 (2002).","DOI":"10.1016\/S0028-3908(01)00172-1"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Kumar N, Laferriere A, Yu JS, Leavitt A, Coderre TJ. Evidence that pregabalin reduces neuropathic pain by inhibiting the spinal release of glutamate. J. Neurochem.<\/i>, 113<\/b>, 552–561 (2010).","DOI":"10.1111\/j.1471-4159.2010.06625.x"},{"key":"11","unstructured":"11) Joshi I, Taylor CP. Pregabalin action at a model synapse: binding to presynaptic calcium channel α2-δ subunit reduces neurotransmission in mice. Eur. J. Pharmacol.<\/i>, 553<\/b>, 82–88 (2006)."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Coderre TJ, Kumar N, Lefebvre CD, Yu JS. Evidence that gabapentin reduces neuropathic pain by inhibiting the spinal release of glutamate. J. Neurochem.<\/i>, 94<\/b>, 1131–1139 (2005).","DOI":"10.1111\/j.1471-4159.2005.03263.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Fehrenbacher JC, Taylor CP, Vasko MR. Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C. Pain<\/i>, 105<\/b>, 133–141 (2003).","DOI":"10.1016\/S0304-3959(03)00173-8"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Bockbrader HN, Wesche D, Miller R, Chapel S, Janiczek N, Burger P. A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin. Clin. Pharmacokinet.<\/i>, 49<\/b>, 661–669 (2010).","DOI":"10.2165\/11536200-000000000-00000"},{"key":"15","unstructured":"15) Vranken JH, Dijkgraaf MG, Kruis MR, van der Vegt MH, Hollmann MW, Heesen M. Pregabalin in patients with central neuropathic pain: a randomized, double-blind, placebo-controlled trial of a flexible-dose regimen. Pain<\/i>, 136<\/b>, 150–157 (2008)."},{"key":"16","unstructured":"16) Baranauskas G, Nistri A. Sensitization of pain pathways in the spinal cord: cellular mechanisms. Prog. Neurobiol.<\/i>, 54<\/b>, 349–365 (1998)."},{"key":"17","unstructured":"17) Petrenko AB, Yamakura T, Baba H, Shimoji K. The role of N<\/i>-methyl-D<\/small>-aspartate (NMDA) receptors in pain: a review. Anesth. Analg.<\/i>, 97<\/b>, 1108–1116 (2003)."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Chaplan SR, Malmberg AB, Yaksh TL. Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat. J. Pharmacol. Exp. Ther.<\/i>, 280<\/b>, 829–838 (1997).","DOI":"10.1016\/S0022-3565(24)36427-4"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Bennett GJ, Chung JM, Honore M, Seltzer Z. Models of neuropathic pain in the rat. Curr. Protoc. Neurosci.<\/i>, Chapter 9, Unit 9, p. 14 (2003).","DOI":"10.1002\/0471141755.ph0532s21"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain<\/i>, 33<\/b>, 87–107 (1988).","DOI":"10.1016\/0304-3959(88)90209-6"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Sacerdote P, Franchi S, Trovato AE, Valsecchi AE, Panerai AE, Colleoni M. Transient early expression of TNF-α in sciatic nerve and dorsal root ganglia in a mouse model of painful peripheral neuropathy. Neurosci. Lett.<\/i>, 436<\/b>, 210–213 (2008).","DOI":"10.1016\/j.neulet.2008.03.023"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Martucci C, Trovato AE, Costa B, Borsani E, Franchi S, Magnaghi V, Panerai AE, Rodella LF, Valsecchi AE, Sacerdote P, Colleoni M. The purinergic antagonist PPADS reduces pain related behaviours and interleukin-1 β, interleukin-6, iNOS and nNOS overproduction in central and peripheral nervous system after peripheral neuropathy in mice. Pain<\/i>, 137<\/b>, 81–95 (2008).","DOI":"10.1016\/j.pain.2007.08.017"},{"key":"23","unstructured":"23) Hylden JL, Wilcox GL. Intrathecal morphine in mice: a new technique. Eur. J. Pharmacol.<\/i>, 67<\/b>, 313–316 (1980)."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Hargreaves K, Dubner R, Brown F, Flores C, Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain<\/i>, 32<\/b>, 77–88 (1988).","DOI":"10.1016\/0304-3959(88)90026-7"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Dunham NW, Miya TS. A note on a simple apparatus for detecting neurological deficit in rats and mice. J. Am. Pharm. Assoc. Am. Pharm. Assoc.<\/i> (Baltim), 46<\/b>, 208–209 (1957).","DOI":"10.1002\/jps.3030460322"},{"key":"26","unstructured":"26) Cowan A. Buprenorphine: new pharmacological aspects. Int. J. Clin. Pract. Suppl.<\/i>, 133<\/b>, 3–8, discussion, 23–24 (2003)."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Xu W, Qiu XC, Han JS. Serotonin receptor subtypes in spinal antinociception in the rat. J. Pharmacol. Exp. Ther.<\/i>, 269<\/b>, 1182–1189 (1994).","DOI":"10.1016\/S0022-3565(25)38857-9"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Hama A, Sagen J. Combination drug therapy for pain following chronic spinal cord injury. Pain Res. Treat.<\/i>, 2012<\/b>, 840486 (2012).","DOI":"10.1155\/2012\/840486"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Fisher K, Coderre TJ, Hagen NA. Targeting the N<\/i>-methyl-D<\/small>-aspartate receptor for chronic pain management. Preclinical animal studies, recent clinical experience and future research directions. J. Pain Symptom Manage.<\/i>, 20<\/b>, 358–373 (2000).","DOI":"10.1016\/S0885-3924(00)00213-X"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Wilson JA, Nimmo AF, Fleetwood-Walker SM, Colvin LA. A randomised double blind trial of the effect of pre-emptive epidural ketamine on persistent pain after lower limb amputation. Pain<\/i>, 135<\/b>, 108–118 (2008).","DOI":"10.1016\/j.pain.2007.05.011"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Cvrcek P. Side effects of ketamine in the long-term treatment of neuropathic pain. Pain Med.<\/i>, 9<\/b>, 253–257 (2008).","DOI":"10.1111\/j.1526-4637.2007.00314.x"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Han DW, Kweon TD, Lee JS, Lee YW. Antiallodynic effect of pregabalin in rat models of sympathetically maintained and sympathetic independent neuropathic pain. Yonsei Med. J.<\/i>, 48<\/b>, 41–47 (2007).","DOI":"10.3349\/ymj.2007.48.1.41"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Gutierrez-Alvarez AM, Beltrán-Rodríguez J, Moreno CB. Antiepileptic drugs in treatment of pain caused by diabetic neuropathy. J. Pain Symptom Manage.<\/i>, 34<\/b>, 201–208 (2007).","DOI":"10.1016\/j.jpainsymman.2006.10.023"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/36\/1\/36_b12-00760\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T16:30:42Z","timestamp":1745944242000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/36\/1\/36_b12-00760\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b12-00760","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}